Related Experiment Video
Updated: Mar 9, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Electrocardiographic left ventricular hypertrophy predicts atrial fibrillation independent of left ventricular mass
Nikhil Patel1, Wesley T O'Neal2, S Patrick Whalen1
1Section of Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Insights
Electrocardiography-left ventricular hypertrophy (ECG-LVH) and echocardiography-left ventricular hypertrophy (echo-LVH) independently predict atrial fibrillation (AF). These findings suggest distinct electrophysiological abnormalities contribute to AF risk.
Area of Science:
- Cardiology
- Electrophysiology
- Preventive Medicine
Background:
- Left ventricular hypertrophy (LVH) is a known cardiovascular risk factor.
- The independent predictive value of ECG-LVH and echo-LVH for atrial fibrillation (AF) remains unclear.
Purpose of the Study:
- To determine if ECG-LVH and echo-LVH independently predict incident AF.
- To investigate the relationship between ECG-LVH, echo-LVH, and AF risk.
Main Methods:
- Analysis of 4,904 participants from the Cardiovascular Health Study, free of baseline AF.
- ECG-LVH defined by Minnesota Code Classification; echo-LVH defined by sex-specific left ventricular mass.
- Cox regression used to assess the association of ECG-LVH and echo-LVH with incident AF.
Main Results:
- ECG-LVH (4.6%) and echo-LVH (4.7%) were independently associated with incident AF (HR=1.50 and HR=1.39, respectively).
- In a combined model, both ECG-LVH (HR=1.47) and echo-LVH (HR=1.36) remained significant predictors of AF.
- Over 11.9 years median follow-up, 1,430 AF events were recorded.
Conclusions:
- ECG-LVH predicts AF independently of left ventricular mass measured by echocardiography.
- Cardiac electrophysiological abnormalities offer a distinct risk profile for predicting AF.
- Both ECG and echocardiography findings of LVH contribute to AF risk prediction.
Background:
Although left ventricular hypertrophy (LVH) detected by electrocardiography (ECG-LVH) and echocardiography (echo-LVH) independently predict cardiovascular disease events, it is unclear if ECG-LVH and echo-LVH independently predict atrial fibrillation (AF).
Methods:
This analysis included 4,904 participants (40% male; 85% white) from the Cardiovascular Health Study who were free of baseline AF and major intraventricular conduction delays. ECG-LVH was defined by Minnesota Code Classification from baseline ECG data. Echo-LVH was defined by sex-specific left ventricular mass values >95th sex-specific percentiles. Incident AF events were identified during the annual study ECGs and from hospitalization discharge data. Cox regression was used to compute hazard ratios (HR) and 95% confidence intervals (CI) for the association of ECG-LVH and echo-LVH with incident AF, separately.
Results:
ECG-LVH was detected in 224 (4.6%) participants and echo-LVH was present in 231 (4.7%) participants. Over a median follow-up of 11.9 years, a total of 1,430 AF events were detected. In a multivariable Cox model adjusted for age, sex, race, education, income, smoking, systolic blood pressure, diabetes, body mass index, total cholesterol, high-density lipoprotein cholesterol, aspirin, antihypertensive medications, and cardiovascular disease, ECG-LVH (HR = 1.50; 95% CI = 1.18, 1.90) and echo-LVH (HR = 1.39; 95% CI = 1.09, 1.78) were independently associated with AF. When ECG-LVH (HR = 1.47, 95% CI = 1.16, 1.87) and echo-LVH (HR = 1.36, 1.07, 1.75) were included in the same model, both were predictive of incident AF.
Conclusion:
The association of ECG-LVH with AF is not dependent on left ventricular mass detected by echocardiography, suggesting that abnormalities in cardiac electrophysiology provide a distinct profile in the prediction of AF.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mitral Stenosis II: Clinical features and Diagnostic Tests

